Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure

Eur Heart J. 2013 Sep;34(36):2792-4. doi: 10.1093/eurheartj/eht279. Epub 2013 Jul 25.

Authors

Luigi Tavazzi¹, Aldo P Maggioni, Jeffrey S Borer

Affiliation

¹ Maria Cecilia Hospital - GVM Care and Research, Ettore Sansavini Health Science Foundation, Via Corriera 1, 48010 Cotignola (RA), Italy.

PMID: 23892200
DOI: 10.1093/eurheartj/eht279

No abstract available

MeSH terms

Adrenergic beta-Antagonists / administration & dosage
Angiotensin Receptor Antagonists / administration & dosage
Angiotensin-Converting Enzyme Inhibitors / administration & dosage
Biomarkers / metabolism
Cardiotonic Agents / administration & dosage*
Chronic Disease
Dose-Response Relationship, Drug
Heart Failure / drug therapy*
Humans
Mineralocorticoid Receptor Antagonists / administration & dosage
Practice Guidelines as Topic
Randomized Controlled Trials as Topic

Substances

Adrenergic beta-Antagonists
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Biomarkers
Cardiotonic Agents
Mineralocorticoid Receptor Antagonists